Agilent Technologies Total Long-Term Assets 2010-2025 | A
Agilent Technologies total long-term assets from 2010 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current
- Agilent Technologies total long-term assets for the quarter ending January 31, 2025 were $7.807B, a 18.11% increase year-over-year.
- Agilent Technologies total long-term assets for 2024 were $7.887B, a 19.92% increase from 2023.
- Agilent Technologies total long-term assets for 2023 were $6.577B, a 2.62% decline from 2022.
- Agilent Technologies total long-term assets for 2022 were $6.754B, a 2.2% decline from 2021.
| Agilent Technologies Annual Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $7,887 |
| 2023 | $6,577 |
| 2022 | $6,754 |
| 2021 | $6,906 |
| 2020 | $6,212 |
| 2019 | $6,263 |
| 2018 | $4,693 |
| 2017 | $4,257 |
| 2016 | $4,159 |
| 2015 | $3,793 |
| 2014 | $5,306 |
| 2013 | $5,703 |
| 2012 | $5,907 |
| 2011 | $3,488 |
| 2010 | $3,527 |
| 2009 | $3,651 |
| Agilent Technologies Quarterly Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2025-01-31 | $7,807 |
| 2024-10-31 | $7,887 |
| 2024-07-31 | $6,740 |
| 2024-04-30 | $6,653 |
| 2024-01-31 | $6,610 |
| 2023-10-31 | $6,577 |
| 2023-07-31 | $6,645 |
| 2023-04-30 | $6,843 |
| 2023-01-31 | $6,841 |
| 2022-10-31 | $6,754 |
| 2022-07-31 | $6,794 |
| 2022-04-30 | $6,812 |
| 2022-01-31 | $6,853 |
| 2021-10-31 | $6,906 |
| 2021-07-31 | $6,859 |
| 2021-04-30 | $6,884 |
| 2021-01-31 | $6,191 |
| 2020-10-31 | $6,212 |
| 2020-07-31 | $6,301 |
| 2020-04-30 | $6,284 |
| 2020-01-31 | $6,399 |
| 2019-10-31 | $6,263 |
| 2019-07-31 | $5,168 |
| 2019-04-30 | $5,210 |
| 2019-01-31 | $5,240 |
| 2018-10-31 | $4,693 |
| 2018-07-31 | $4,682 |
| 2018-04-30 | $4,259 |
| 2018-01-31 | $4,301 |
| 2017-10-31 | $4,257 |
| 2017-07-31 | $4,265 |
| 2017-04-30 | $4,216 |
| 2017-01-31 | $4,237 |
| 2016-10-31 | $4,159 |
| 2016-07-31 | $4,204 |
| 2016-04-30 | $4,152 |
| 2016-01-31 | $3,903 |
| 2015-10-31 | $3,793 |
| 2015-07-31 | $3,773 |
| 2015-04-30 | $3,792 |
| 2015-01-31 | $3,865 |
| 2014-10-31 | $5,306 |
| 2014-07-31 | $5,546 |
| 2014-04-30 | $5,649 |
| 2014-01-31 | $5,565 |
| 2013-10-31 | $5,703 |
| 2013-07-31 | $5,694 |
| 2013-04-30 | $5,769 |
| 2013-01-31 | $5,941 |
| 2012-10-31 | $5,907 |
| 2012-07-31 | $5,546 |
| 2012-04-30 | $3,403 |
| 2012-01-31 | $3,384 |
| 2011-10-31 | $3,488 |
| 2011-07-31 | $3,530 |
| 2011-04-30 | $3,553 |
| 2011-01-31 | $3,446 |
| 2010-10-31 | $3,527 |
| 2010-07-31 | $3,365 |
| 2010-04-30 | $2,055 |
| 2010-01-31 | $2,055 |
| 2009-10-31 | $3,651 |
| 2009-07-31 | $3,676 |
| 2009-04-30 | $3,693 |
| 2009-01-31 | $4,154 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $30.677B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.763B | 27.35 |
| Boston Scientific (BSX) | United States | $152.152B | 38.10 |
| Stryker (SYK) | United States | $142.721B | 30.67 |
| EssilorLuxottica (ESLOY) | France | $133.556B | 0.00 |
| Medtronic (MDT) | Ireland | $108.708B | 15.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.613B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.796B | 26.03 |
| ResMed (RMD) | United States | $34.691B | 26.06 |
| GE HealthCare Technologies (GEHC) | United States | $32.200B | 15.29 |
| Terumo (TRUMY) | Japan | $28.397B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.827B | 17.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.388B | 12.88 |
| Insulet (PODD) | United States | $17.717B | 75.76 |
| Baxter (BAX) | United States | $15.988B | 11.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.272B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Demant (WILYY) | Denmark | $7.600B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.145B | 17.57 |
| Bio-Rad Laboratories (BIO) | United States | $6.837B | 23.67 |
| Prestige Consumer Healthcare (PBH) | United States | $4.024B | 19.20 |
| Perrigo (PRGO) | Ireland | $3.510B | 10.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.362B | 28.64 |
| Haemonetics (HAE) | United States | $3.166B | 14.90 |
| Envista Holdings (NVST) | United States | $2.725B | 22.03 |
| GN Store Nord (GNNDY) | Denmark | $2.260B | 18.72 |
| LeMaitre Vascular (LMAT) | United States | $2.050B | 46.77 |
| QuidelOrtho (QDEL) | United States | $1.875B | 15.70 |
| AtriCure (ATRC) | United States | $1.480B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.401B | 22.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.235B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.148B | 11.05 |
| BioLife Solutions (BLFS) | United States | $1.145B | 0.00 |
| Neogen (NEOG) | United States | $1.096B | 14.03 |
| InMode (INMD) | Israel | $0.981B | 8.98 |
| Phibro Animal Health (PAHC) | United States | $0.754B | 11.56 |
| Evolus (EOLS) | United States | $0.735B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.713B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.580B | 0.00 |
| CeriBell (CBLL) | United States | $0.577B | 0.00 |
| Owens & Minor (OMI) | United States | $0.545B | 4.64 |
| Valneva SE (VALN) | France | $0.531B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.488B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.479B | 0.00 |
| Omeros (OMER) | United States | $0.427B | 0.00 |
| Surmodics (SRDX) | United States | $0.400B | 0.00 |
| SNDL (SNDL) | Canada | $0.392B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.357B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.343B | 14.86 |
| Verano Holdings (VRNOF) | United States | $0.323B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.279B | 25.25 |
| Aurora Cannabis (ACB) | Canada | $0.261B | 46.40 |
| Canopy Growth (CGC) | Canada | $0.254B | 0.00 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| ZimVie (ZIMV) | United States | $0.252B | 15.10 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.231B | 0.00 |
| Quanterix (QTRX) | United States | $0.223B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| Biote (BTMD) | United States | $0.182B | 4.16 |
| Utah Medical Products (UTMD) | United States | $0.170B | 13.69 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 51.00 |
| Organigram Global (OGI) | Canada | $0.146B | 0.00 |
| Jin Medical (ZJYL) | China | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.142B | 17.46 |
| TerrAscend (TSNDF) | Canada | $0.128B | 0.00 |
| Agape ATP (ATPC) | $0.115B | 0.00 | |
| Exagen (XGN) | United States | $0.112B | 0.00 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.082B | 0.00 |
| Veru (VERU) | United States | $0.079B | 0.00 |
| Fonar (FONR) | United States | $0.078B | 10.91 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Apyx Medical (APYX) | United States | $0.039B | 0.00 |
| Safety Shot (SHOT) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 54.00 |
| United-Guardian (UG) | United States | $0.036B | 11.14 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |